Promoterless gene targeting without nucleases rescues lethality of a Crigler‐Najjar syndrome mouse model
Abstract Crigler‐Najjar syndrome type I (CNSI) is a rare monogenic disease characterized by severe neonatal unconjugated hyperbilirubinemia with a lifelong risk of neurological damage and death. Liver transplantation is the only curative option, which has several limitations and risks. We applied an...
| Published in: | EMBO Molecular Medicine |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2017-07-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201707601 |
